Michael Morgan

4.2k total citations
60 papers, 3.0k citations indexed

About

Michael Morgan is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Michael Morgan has authored 60 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 11 papers in Pharmacology. Recurrent topics in Michael Morgan's work include Neurotransmitter Receptor Influence on Behavior (10 papers), Receptor Mechanisms and Signaling (10 papers) and Diabetes Treatment and Management (6 papers). Michael Morgan is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (10 papers), Receptor Mechanisms and Signaling (10 papers) and Diabetes Treatment and Management (6 papers). Michael Morgan collaborates with scholars based in United States, United Kingdom and Australia. Michael Morgan's co-authors include James W. Gibb, Bradley D. Anderson, S V Perry, J. H. Ottaway, Barbara Silverstein, Adair J. Hotchkiss, Peregrin Spielholz, Harvey Checkoway, Joel D. Kaufman and Dharmendra Singhal and has published in prestigious journals such as The Journal of Cell Biology, The EMBO Journal and Molecular and Cellular Biology.

In The Last Decade

Michael Morgan

56 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Morgan United States	25	911	725	612	314	280	60	3.0k
Changjong Moon South Korea	43	1.8k 1.9×	852 1.2×	322 0.5×	143 0.5×	110 0.4×	348	6.3k
Krishnan M. Dhandapani United States	44	2.4k 2.6×	793 1.1×	400 0.7×	567 1.8×	56 0.2×	111	6.1k
Tapas Chandra Nag India	38	1.4k 1.6×	433 0.6×	220 0.4×	327 1.0×	79 0.3×	212	4.3k
Leah R. Hanson United States	33	1.4k 1.5×	882 1.2×	168 0.3×	159 0.5×	335 1.2×	92	4.6k
Diego Albani Italy	35	1.1k 1.2×	526 0.7×	369 0.6×	96 0.3×	151 0.5×	140	3.9k
Abolhassan Ahmadiani Iran	35	1.7k 1.9×	913 1.3×	496 0.8×	417 1.3×	216 0.8×	173	5.2k
Björn Bauer United States	36	1.6k 1.7×	697 1.0×	329 0.5×	155 0.5×	361 1.3×	49	6.2k
Hyun‐Woo Kim South Korea	41	1.8k 2.0×	957 1.3×	878 1.4×	173 0.6×	221 0.8×	224	5.4k
Eitan Okun Israel	33	1.5k 1.7×	668 0.9×	210 0.3×	185 0.6×	217 0.8×	79	5.1k

Countries citing papers authored by Michael Morgan

Since Specialization

Citations

This map shows the geographic impact of Michael Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Morgan more than expected).

Fields of papers citing papers by Michael Morgan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Morgan. The network helps show where Michael Morgan may publish in the future.

Co-authorship network of co-authors of Michael Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Morgan. A scholar is included among the top collaborators of Michael Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Morgan. Michael Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Varty, Geoffrey B., Clinton E. Canal, Joshua A. Hartsel, et al.. (2024). Synthesis and Structure–Activity Relationships of 2,5-Dimethoxy-4-Substituted Phenethylamines and the Discovery of CYB210010: A Potent, Orally Bioavailable and Long-Acting Serotonin 5-HT₂ Receptor Agonist. Journal of Medicinal Chemistry. 67(8). 6144–6188. 1 indexed citations

Muñoz, Iván, Michael Morgan, Julien Peltier, et al.. (2018). Phosphoproteomic screening identifies physiological substrates of the CDKL 5 kinase. The EMBO Journal. 37(24). 53 indexed citations

Schreiber, Stefan, Michael Morgan, Ronald Christopher, et al.. (2017). P-180 Etrasimod (APD334), a Potent, Selective, Oral S1P Receptor Modulator with Autoimmune Disease-Modifying Activity Exhibiting Favorable PK/PD Properties in Healthy Volunteers. Inflammatory Bowel Diseases. 23. 2 indexed citations

Christopher, Ronald, Michael Morgan, Yong Tang, et al.. (2017). Pharmacokinetics and Tolerability of Lorcaserin in Special Populations: Elderly Patients and Patients with Renal or Hepatic Impairment. Clinical Therapeutics. 39(4). 837–848.e7. 7 indexed citations

Grottick, Andrew J., et al.. (2014). Investigating interactions between phentermine, dexfenfluramine, and 5-HT2C agonists, on food intake in the rat. Psychopharmacology. 232(11). 1973–1982. 10 indexed citations

Semple, Graeme, Albert Ren, Beatriz Fioravanti, et al.. (2011). Discovery of fused bicyclic agonists of the orphan G-protein coupled receptor GPR119 with in vivo activity in rodent models of glucose control. Bioorganic & Medicinal Chemistry Letters. 21(10). 3134–3141. 53 indexed citations

Semple, Graeme, Juerg Lehmann, Albert Ren, et al.. (2011). Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improved profile. Bioorganic & Medicinal Chemistry Letters. 22(4). 1750–1755. 39 indexed citations

Semple, Graeme, Thuy-Anh Tran, Sangdon Han, et al.. (2009). Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: In vitro profiling and in vivo evaluation. Bioorganic & Medicinal Chemistry Letters. 19(21). 6166–6171. 3 indexed citations

Al‐Shamma, Hussien, Christen M. Anderson, Emil Chuang, et al.. (2009). Nelotanserin, a Novel Selective Human 5-Hydroxytryptamine2A Inverse Agonist for the Treatment of Insomnia. Journal of Pharmacology and Experimental Therapeutics. 332(1). 281–290. 30 indexed citations

10.

Ramirez, Juan Ignacio, Yunqing Shi, William Thomsen, et al.. (2007). Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonist. European Journal of Pharmacology. 586(1-3). 234–243. 19 indexed citations

11.

Savolainen, Jouko, Jeffrey E. Edwards, Michael Morgan, Patrick J. McNamara, & Bradley D. Anderson. (2002). Effects of a P-Glycoprotein Inhibitor on Brain and Plasma Concentrations of Anti-Human Immunodeficiency Virus Drugs Administered in Combination in Rats. Drug Metabolism and Disposition. 30(5). 479–482. 24 indexed citations

12.

Zentner, Gaylen M., Ramesh Rathi, Hunseung Oh, et al.. (2001). Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. Journal of Controlled Release. 72(1-3). 203–215. 474 indexed citations

13.

Perkinton, Michael S., et al.. (1998). Hydrogen Peroxide Enhances Signal‐Responsive Arachidonic Acid Release from Neurons: Role of Mitogen‐Activated Protein Kinase. Journal of Neurochemistry. 70(5). 2082–2090. 73 indexed citations

14.

Morgan, Michael, Kui Liu, & Bradley D. Anderson. (1998). Microscale Titrimetric and Spectrophotometric Methods for Determination of Ionization Constants and Partition Coefficients of New Drug Candidates. Journal of Pharmaceutical Sciences. 87(2). 238–245. 21 indexed citations

15.

Singhal, Dharmendra, Michael Morgan, & Bradley D. Anderson. (1997). Role of Brain Tissue Localized Purine Metabolizing Enzymes in the Central Nervous System Delivery of Anti-HIV Agents 2′-β-Fluoro-2,3′-Dideoxyinosine and 2′-β-Fluoro-2′,3′-Dideoxyadenosine in Rats. Pharmaceutical Research. 14(6). 786–792. 20 indexed citations

16.

Morgan, Michael, et al.. (1997). Ethanol modulates N-methyl-d-aspartate-evoked arachidonic acid release from neurones. European Journal of Pharmacology. 340(1). 27–34. 15 indexed citations

17.

Anderson, Bradley D., Michael Morgan, & Dharmendra Singhal. (1995). Enhanced Oral Bioavailability of DDI After Administration of 6-Cl-ddP, an Adenosine Deaminase-Activated Prodrug, to Chronically Catheterized Rats. Pharmaceutical Research. 12(8). 1126–1133. 18 indexed citations

18.

Nielson, Christopher, Joseph J. Crowley, Michael Morgan, & Robert E. Vestal. (1988). Polymorphonuclear Leukocyte Inhibition by Therapeutic Concentrations of Theophylline Is Mediated by Cyclic-3′, 5′-Adenosine Monophosphate. American Review of Respiratory Disease. 137(1). 25–30. 68 indexed citations

19.

Covert, David S., et al.. (1981). Interaction of acid sulfates and the respiratory system. Final report. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 47(1). 91–7. 1 indexed citations

20.

Bakhit, Charles, Michael Morgan, MA Peat, & James W. Gibb. (1981). Long-term effects of methamphetamine on the synthesis and metabolism of 5-hydroxytryptamine in various regions of the rat brain. Neuropharmacology. 20(12). 1135–1140. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact